Barclays analyst Benjamin Budish raised the firm’s price target on CME Group to $209 from $208 and keeps an Equal Weight rating on the shares following the Q2 report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME:
- CME Group Inc. Reports All-Time Record Revenue of $1.5 Billion for Q2 2024
- CME Upcoming Earnings Report: What to Expect?
- CME Group price target lowered to $208 from $228 at Barclays
- CME Group price target lowered to $235 from $250 at Piper Sandler
- CME Group (NASDAQ:CME): The Next Great Dividend Stock